02397cam a2200433 i 4500001001900000003000500019008004100024010001300065020001500078027002100093035002000114037001100134040001900145043001200164050002000176100003600196245009300232264003700325300004300362336002600405337002600431337002800457338003600485338002700521500003500548504005200583520085100635530005801486588004701544610009301591650005101684650003801735650001401773650001401787710003801801710002101839710002501860856007801885rnd000000000111884RAND930407s1993    caua     b    000 0 eng d  a93012592  a0833013459  aRAND/MR-166-DPRC  a(Sirsi) a337046  c$13.00  aCstmoRcCstmoR  an-us--- 4aHD7102.U4bR5541 aRogowski, Jeannette A.eauthor.10aPrivate versus public sector insurance coverage for drug abuse /cJeannette A. Rogowski. 1aSanta Monica, CA :bRAND,c1993.  axi, 53 pages :billustrations ;c28 cm  atextbtxt2rdacontent  acomputerbc2rdamedia  aunmediatedbn2rdamedia  aonline resourcebcr2rdacarrier  avolumebnc2rdacarrier  a"Drug Policy Research Center."  aIncludes bibliographical references (p. 51-53).  aThis study examined financing mechanisms currently in place for treating drug abuse, focusing primarily on differences between private and public insurance mechanisms. Within the private sector, insurance coverage for drug abuse treatment is quite restrictive. Limitations typically exist on the type and amount of treatment that can be received per year or per lifetime, and benefits may quickly be exhausted. Limitations also exist with regard to public insurance funding. Eligibility requirements and the authorized settings in which care may be provided are extremely restrictive. It has been argued that public funding for drug abuse should be mainstreamed into Medicaid. However, this is not likely to occur due to significant institutional barriers, and in particular to the highly restrictive eligibility requirements for public programs.  aAlso available on the internet via WWW in PDF format.  aDescription based on print version record.10aUnited States.bOffice of Civilian Health and Medical Program of the Uniformed Services. 0aDrug abusexTreatmentzUnited StatesxFinance. 0aInsurance, HealthzUnited States. 0aMedicaid. 0aMedicare.2 aRAND Drug Policy Research Center.2 aFord Foundation.2 aWeingart Foundation.41yOnline Accessu http://www.rand.org/pubs/monograph_reports/2006/MR166.pdf